Dr. Pascal Longchamp is the Chief Corporate & Commercial Officer of Scarab Genomics LLC. Dr. Longchamp has spent over 20 years in the Biotechnology & Pharmaceutical industry, covering Corporate, Management, Business Development and R&D positions on the West Coast (US) and in Switzerland. He has been the Chief Business Officer of Evolva SA from 2005 to 2018, a Swiss listed company using a unique synthetic biology platform to developing NCE for Pharmaceuticals and the manufacturing of complex chemistry. Previously he was the Director of Business Development at Phyllom LLC (2003), where he developed its Vaccines and Agricultural franchises, and a part of Maxygen's successful IPO in December 1999. At Maxygen, Dr. Longchamp was in charge of two corporate alliances and promotion of its gene shuffling platform technology to third parties. At Evolva SA, Phistem LLC, Maxygen Inc. and Phyllom LLC, Dr. Longchamp was responsible for corporate development, strategic alliances, in and out-licensing, leading international research collaboration and US government contract with the Department of Defense. He received a Ph.D. in Genetics and Microbiology from the University of Lausanne, followed by post-doctoral researches at UC Berkeley in Molecular Biology and at Lawrence Berkeley National Laboratory in Biodefense. Dr. Longchamp has an MBA from HEC Business School, Lausanne. Dr. Longchamp has also been a founder and Chairman of the Board of Phistem LLC (2009-2013) a cancer stem cell focused company.